US2022213500A1PendingUtilityA1
Expression Process
Assignee: FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LTDPriority: May 3, 2013Filed: Mar 15, 2022Published: Jul 7, 2022
Est. expiryMay 3, 2033(~6.8 yrs left)· nominal 20-yr term from priority
C12N 15/85C07K 2317/14C07K 2319/02C07K 16/30C07K 16/3092C07K 16/065
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A process for the production of a target polypeptide is provided. The process comprises expression of an expression vector for expressing a target polypeptide in a host cell, preferably a mammalian cell, the expression vector comprising an expression cassette comprising a polynucleotide encoding a recombinant polypeptide operably linked to a fibronectin secretion leader sequence; and recovering the target polypeptide.
Claims
exact text as granted — not AI-modified1 - 25 . (canceled)
26 . A process of producing a target polypeptide which comprises:
(a) expressing an expression vector for expressing a target polypeptide in a Chinese hamster ovary (CHO) host cell, the expression vector comprising an expression cassette comprising a polynucleotide encoding a recombinant polypeptide operably linked to a fibronectin secretion leader sequence comprising SEQ ID NO: 2 or a sequence having 90% sequence identity to SEQ ID NO: 2 and retaining the ability to secrete the target polypeptide; and (b) recovering the target polypeptide.
27 . A process of producing a target polypeptide which comprises:
(a) transfection or transformation of a Chinese hamster ovary (CHO) host cell with an expression vector for expressing a target polypeptide in a host cell, the expression vector comprising an expression cassette comprising a polynucleotide encoding the target polypeptide operably linked to a fibronectin secretion leader sequence comprising SEQ ID NO: 2 or a sequence having 90% sequence identity to SEQ ID NO: 2 and retaining the ability to secrete the target polypeptide; (b) culturing the host cell under conditions which allow proliferation of the host cell and expression and secretion of the target polypeptide from the host cell; and (c) recovering the target polypeptide.
28 . The process according to claim 26 , wherein the fibronectin secretion leader sequence corresponds to the host cell.
29 . The process according to claim 26 , wherein the expression cassette comprises a human elongation factor la (hEF1a) promoter.
30 . The process according to claim 29 , wherein the expression cassette comprises a polyA sequence.
31 . The process according to claim 30 , wherein the poly A sequence is selected from human betaglobin polyA, bovine growth hormone polyA, SV40 early and SV40 late sequences.
32 . The process according to claim 26 , wherein two expression cassettes are employed, a first expression cassette comprising a polynucleotide encoding a light chain of a monoclonal antibody, and a second expression cassette comprising a polynucleotide encoding a heavy chain of a monoclonal antibody.
33 . The process according to claim 32 , wherein the two expression cassettes comprise the same promoter, secretion leader and polyA sequence.
34 . The process according to claim 33 , wherein the promoter is a human elongation factor 1 a (hEF1a) promoter, the fibronectin secretion leader is Chinese hamster fibronectin secretion leader and the polyA sequence is bovine betaglobin polyA sequence.
35 . A process for the production of a target polypeptide, the process comprising culturing a Chinese hamster ovary cell (CHO) transfected with an expression vector comprising an expression cassette comprising a polynucleotide encoding the target polypeptide operably linked to a fibronectin secretion leader sequence comprising SEQ ID NO: 2 or a sequence having 90% sequence identity to SEQ ID NO: 2 and retaining the ability to secrete the target polypeptide.Join the waitlist — get patent alerts
Track US2022213500A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.